X4 Pharmaceuticals, Inc. buy B. Riley
Start price
31.08.23
/
50%
€1.19
Target price
31.08.24
-
Performance (%)
-22.90%
Price
04.06.24
€0.98
Summary
This prediction is currently active. The price of X4 Pharmaceuticals, Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.90%. This prediction currently runs until 31.08.24. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
X4 Pharmaceuticals, Inc. | 8.794% | 8.794% |
iShares Core DAX® | 0.805% | 2.118% |
iShares Nasdaq 100 | 1.995% | 4.071% |
iShares Nikkei 225® | 1.264% | -2.374% |
iShares S&P 500 | 1.637% | 2.287% |
Comments by B__Riley for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at B. Riley.
Ratings data for XFOR provided by MarketBeat